NEW YORK (GenomeWeb) – Helomics has signed an agreement to act as the clinical laboratory for Ariel Precision Medicine's PancreasDx pancreatic disease assay, the Pittsburgh-based companies announced today.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.
This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.